Skip to Main Content
TRC_PLC_New
Menu
    • Products
      • CriticalPoint
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • NatMed Advisor
      • NatMed Pro
      • NetCE All Access
      • NetCE All Access: Behaviorial Health
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber Insights
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Featured Charts & Graphics
    • Gender-Related Care
    • Natural Medicines Resources
    • All Charts & Graphics
  • Podcasts
  • Charts & Graphics
    • Featured Charts & Graphics
    • New Drugs
    • Do Not Crush List
    • Stepwise Treatment of Type 2 Diabetes
    • Contraceptives
    • Antidepressants
    • All Charts & Graphics >
  • CE/CME & Training
    • CE Organizer
    • Available Courses
    • My Completions
    • Live Webinars
  • Help
    • User Support
    • Contact Us

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

NatMed Pro, the largest natural medicines database, just got a major upgrade! With faster performance, a redesigned interface, and improved navigation, it's easier than ever to find the evidence-based answer you need. Explore Now
  1. Home
  2. Browse
  3. Bone & Joint
  4. Rheumatoid Arthritis
  5. Treatment

Treatment

  • Fibromyalgia (28)
  • Fractures (10)
  • Gout (25)
  • Lupus (7)
  • Musculoskeletal (18)
  • Orthopedics (9)
  • Osteoarthritis (79)
  • Osteopathy (2)
  • Osteoporosis (194)
  • Other (22)
  • Resources (141)
  • Rheumatoid Arthritis (72)
    • Drug Toxicity (36)
    • Natural Medicines / Supplements (10)
    • Treatment (52)
16 - 30 of 52 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Article: Recommend the New Biosimilar Brenzys as a Cheaper Alternative to Enbrel January 2017
Chart: Brenzys and Enbrel Comparison January 2017
Chart: Safety Comparison of NSAIDs January 2017
Article: Watch for More Frequent Fine-Tuning of Rheumatoid Arthritis Meds June 2016
Other: Rheumatoid Arthritis June 2016
Article: Advise Limiting NSAIDs in Patients With Cardiovascular Disease September 2015
Article: Recommend NOT Going Over 100 mg/day of Diclofenac Orally or Rectally November 2014
Commentary: Diclofenac: Cardiovascular Safety Information and Dose Change November 2014
Article: Recommend Folic Acid for Rheumatoid Arthritis Patients on Methotrexate October 2014
Article: Don't Automatically Substitute Remsima or Inflectra for Remicade October 2014
Commentary: Infliximab Subsequent Entry Biologics October 2014
Article: Xeljanz (ZEL-jans, tofacitinib), a new ORAL treatment for moderate to severe rheumatoid arthritis in adults September 2014
Commentary: DMARDs in the Treatment of Rheumatoid Arthritis September 2014
Article: Simponi (golimumab) is a new option for treating ulcerative colitis in adults December 2013
Commentary: Simponi (Golimumab) for Ulcerative Colitis December 2013
  • « Prev
  • 1
  • 2
  • 3
  • 4
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.



© Therapeutic Research Center. All Rights Reserved